Lexington Medical Center is pleased to announce that it is affiliating with Duke Medicine to provide a state-of-the-art level of cancer care to patients in our community. This collaboration with Duke will allow Lexington Medical Center patients to have access to Dukeâ€™s excellence in cancer patient care, clinical research and education. Lexington Medical Centerâ€™s comprehensive cancer services will be a premiere program within the Midlands.
â€œLexington Medical Centerâ€™s affiliation with the Duke Oncology Network will allow patients to receive the best cancer care available, including access to important clinical trials, right here in our community,â€ said Mike Biediger, President & CEO of Lexington Medical Center.
Through this affiliation, the Duke Oncology Network will work on a consulting basis to provide Lexington Medical Center physicians with mentors at Duke and enhance policies and procedures. Importantly, the oncology affiliation with Duke will allow Lexington Medical Center to increase patient access to cutting edge clinical trials, exposing people in the Midlands to a wide range of the most promising cancer treatments currently available in the nation. Duke will also offer Lexington Medical Center guidance in areas including oncology clinical practice, program development and continuing medical education.
â€œOur cancer patients can feel confident knowing their care is guided not only by the excellent, multi-disciplinary oncology team at Lexington Medical Center, but also by the expertise of Dukeâ€™s quality program,â€ said Dr. Steve Madden, oncologist at Lexington Oncology Associates, a Lexington Medical Center physician practice.
The Duke Cancer Institute is consistently ranked among the top centers in the nation for cancer services and is one of only 41 comprehensive cancer centers designated by the National Cancer Institute. The Duke Cancer Institute serves more than 6,000 new cancer patients each year, from every state in the nation. – less – More from ZoomInfo »